FINWIRES · TerminalLIVE
FINWIRES

Vir Biotechnology Doses First Expansion Cohort Patient in Phase 1 Metastatic Prostate Cancer Trial

By

Vir Biotechnology (VIR) said Monday it has dosed the first patient in one of three expansion cohorts in a phase 1 trial assessing safety, pharmacokinetics and efficacy of VIR-5500 in metastatic prostate cancer.

The company said the monotherapy expansion cohort in late-line metastatic castration-resistant prostate cancer is the first to begin enrollment.

Vir said it expects to dose the first patients in the dose-expansion cohorts to evaluate VIR-5500 combined with an androgen receptor pathway inhibitor in early-line metastatic castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer, in the coming months.

The company said it expects to launch pivotal phase 3 trials in 2027.

Shares of Vir Biotechnology were down 1% in Monday trading.

Price: $9.40, Change: $-0.10, Percent Change: -1.05%

Related Articles

Wire

Children's Place Fiscal Q4 Adjusted Loss Widens, Revenue Falls; Shares Drop After Hours

Children's Place (PLCE) reported a fiscal Q4 adjusted loss late Friday of $1.86 per diluted share, widening from the loss of $0.75 a year earlier.One analyst polled by FactSet expected a loss of $0.96.Revenue in the three months ended Jan. 31 fell to $329.2 million from $408.6 million a year earlier.One analyst surveyed by FactSet expected $358.3 million.Children's Place shares fell 19% in after-hours trading.

$PLCE
Wire

Market Chatter: Epic Games' Fortnite Resurgence Hinges on Walt Disney Partnership

Epic Games is pinning its Fortnite rebound on its game development with Walt Disney (DIS) after rushing product releases to chase trends backfired, Bloomberg reported Friday, citing company employees.The company acknowledged that new games, Fortnite upgrades, and a new mobile store did not live up to expectations, according to the sources.The first game under the partnership with Disney is expected to launch in November, with at least two more games expected in the future, the media outlet reported.Epic Games did not immediately respond to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $99.01, Change: $-0.79, Percent Change: -0.79%

$DIS
Wire

Top Cryptocurrencies Rise; Bitcoin Holds Above $73,000 Level

Major digital assets rose Friday, with Bitcoin (BTC-USD) holding above the $73,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 1.2% in the past 24 hours. The Nasdaq 100 rose 0.1%, the S&P 500 fell 0.2%, and the Dow Jones Industrial Average decreased 0.6%.Bitcoin rose 1.2% to $73,110, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume rose 10.3% to $39.1 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, climbed 1.3% to $2,250.XRP (XRP-USD) advanced 0.3%, BNB (BNB-USD) was little changed, and Solana (SOL-USD) rose 1.4%. Dogecoin (DOGE-USD) climbed 1.2%, while Cardano (ADA-USD) gained 0.7%.The US 10-year Treasury yield stood at 4.315% at 3 p.m. ET Friday, up from 4.287% Thursday, while the five-year yield rose to 3.939% from 3.911%.The total market value of the cryptocurrency industry advanced 1.4% in the past 24 hours to $2.48 trillion, with trading volume gaining 1% to $149.95 billion.Price: $73096.51, Change: $+1312.99, Percent Change: +1.83%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD